Simplex Trading
QNCX icon

Simplex Trading’s Quince Therapeutics QNCX Stock Holding History

Simplex Trading’s Portfolio QNCX Stock Details QNCX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$32.9K Buy
1,631
+1,264
+344% +$254K ﹤0.01% 6293
2025
Q4 		$246K Buy
367
+286
+353% +$144K ﹤0.01% 4018
2025
Q3 		$26K Sell
81
-68
-46% -$22.6K ﹤0.01% 7108
2025
Q2 		$49K Sell
149
-23
-13% -$5.26K ﹤0.01% 5940
2025
Q1 		$45K Sell
172
-79
-31% -$24.1K ﹤0.01% 5880
2024
Q4 		$93K Buy
251
+224
+830% +$67.3K ﹤0.01% 5245
2024
Q3 		$4K Buy
+27
New +$3.87K ﹤0.01% 7760
2023
Q4 		– Sell
-109
Closed -$24K – 9622
2023
Q3 		$24K Hold
109
– – ﹤0.01% 6479
2023
Q2 		$32K Sell
109
-23
-17% -$7.16K ﹤0.01% 6299
2023
Q1 		$41K Buy
132
+3
+2% +$587 ﹤0.01% 6151
2022
Q4 		$16K Buy
129
+18
+16% +$3.01K ﹤0.01% 7095
2022
Q3 		$29K Sell
111
-37
-25% -$14.1K ﹤0.01% 7115
2022
Q2 		$65K Sell
148
-138
-48% -$97.5K ﹤0.01% 6151
2022
Q1 		$354K Buy
286
+50
+21% +$68K ﹤0.01% 4309
2021
Q4 		$595K Sell
236
-6
-2% -$36.6K ﹤0.01% 3562
2021
Q3 		$2.67M Hold
242
– – ﹤0.01% 1801
2021
Q2 		$2.56M Buy
242
+240
+12,000% +$2.01M ﹤0.01% 1852
2021
Q1 		$1.36M Buy
+2
New +$14.4K ﹤0.01% 2070
2020
Q4 		– Hold
0
– – – 5603

Other funds holding QNCX

WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SC
Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.5B AUM 75.26% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Simplex Trading's QNCX Position: Q1 2026 in Review

Simplex Trading reduced its Quince Therapeutics (QNCX) stake by 7.9% in Q1 2026, selling an estimated $13.2K and leaving 770 shares worth $15.6K. The position accounts for ﹤0.01% of the portfolio, ranked #6966.

Simplex Trading first reported a position in QNCX in Q3 2020 and has held it in 10 quarters since. The position peaked at $560K in Q4 2025. 43 funds tracked by Wall St. Rank hold QNCX as of Q1 2026.

  • Simplex Trading held 770 shares of Quince Therapeutics worth $15.6K as of Q1 2026.
  • Simplex Trading sold 66 Quince Therapeutics shares in Q1 2026, an estimated $13.2K.
  • Quince Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #6966 holding.
  • Simplex Trading first reported a position in Quince Therapeutics in Q3 2020 and has held it in 10 quarters since.
  • Simplex Trading's Quince Therapeutics position peaked at $560K in Q4 2025.
  • 43 funds tracked by Wall St. Rank held Quince Therapeutics as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.